National Academy of Sciences (1996)

Albert Lasker Clinical Medical Research Award (1996) For groundbreaking work and bold, visionary and imaginative leadership in the development and commercialization of the Hemophilus influenzae type b vaccine and bringing the vaccine to market, leading to the eradication of Hemophilus influenzae type b, typhoid, and pneumococcus. More

National Academy of Medicine (1993)